144 related articles for article (PubMed ID: 9557609)
1. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality.
Sankar M; Tanaka K; Kumaravel TS; Arif M; Shintani T; Yagi S; Kyo T; Dohy H; Kamada N
Leukemia; 1998 Apr; 12(4):510-6. PubMed ID: 9557609
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
Lai JL; Preudhomme C; Zandecki M; Flactif M; Vanrumbeke M; Lepelley P; Wattel E; Fenaux P
Leukemia; 1995 Mar; 9(3):370-81. PubMed ID: 7885035
[TBL] [Abstract][Full Text] [Related]
3. dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.
Wang P; Spielberger RT; Thangavelu M; Zhao N; Davis EM; Iannantuoni K; Larson RA; Le Beau MM
Genes Chromosomes Cancer; 1997 Nov; 20(3):282-91. PubMed ID: 9365836
[TBL] [Abstract][Full Text] [Related]
4. Frequent allelic loss of the RB, D13S319 and D13S25 locus in myeloid malignancies with deletion/translocation at 13q14 of chromosome 13, but not in lymphoid malignancies.
Tanaka K; Arif M; Eguchi M; Guo SX; Hayashi Y; Asaoku H; Kyo T; Dohy H; Kamada N
Leukemia; 1999 Sep; 13(9):1367-73. PubMed ID: 10482987
[TBL] [Abstract][Full Text] [Related]
5. 17p Deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ.
Soenen V; Preudhomme C; Roumier C; Daudignon A; Laï JL; Fenaux P
Blood; 1998 Feb; 91(3):1008-15. PubMed ID: 9446663
[TBL] [Abstract][Full Text] [Related]
6. Molecular and transcriptional characterization of 17p loss in B-cell chronic lymphocytic leukemia.
Fabris S; Mosca L; Todoerti K; Cutrona G; Lionetti M; Intini D; Matis S; Colombo M; Agnelli L; Gentile M; Spriano M; Callea V; Festini G; Molica S; Lambertenghi Deliliers G; Morabito F; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2008 Sep; 47(9):781-93. PubMed ID: 18521849
[TBL] [Abstract][Full Text] [Related]
7. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes.
Sánchez-Castro J; Marco-Betés V; Gómez-Arbonés X; García-Cerecedo T; López R; Talavera E; Fernández-Ruiz S; Ademà V; Marugan I; Luño E; Sanzo C; Vallespí T; Arenillas L; Marco Buades J; Batlle A; Buño I; Martín Ramos ML; Blázquez Rios B; Collado Nieto R; Vargas MT; González Martínez T; Sanz G; Solé F; ;
Leuk Lymphoma; 2015; 56(11):3183-8. PubMed ID: 25754580
[TBL] [Abstract][Full Text] [Related]
9. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias.
Fischer K; Fröhling S; Scherer SW; McAllister Brown J; Scholl C; Stilgenbauer S; Tsui LC; Lichter P; Döhner H
Blood; 1997 Mar; 89(6):2036-41. PubMed ID: 9058725
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases.
Le Beau MM; Espinosa R; Neuman WL; Stock W; Roulston D; Larson RA; Keinanen M; Westbrook CA
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5484-8. PubMed ID: 8516290
[TBL] [Abstract][Full Text] [Related]
11. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion.
Sebaa A; Ades L; Baran-Marzack F; Mozziconacci MJ; Penther D; Dobbelstein S; Stamatoullas A; Récher C; Prebet T; Moulessehoul S; Fenaux P; Eclache V
Genes Chromosomes Cancer; 2012 Dec; 51(12):1086-92. PubMed ID: 22933333
[TBL] [Abstract][Full Text] [Related]
12. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
13. A FISH comparison of variant derivatives of the recurrent dic(17;20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes.
MacKinnon RN; Patsouris C; Chudoba I; Campbell LJ
Genes Chromosomes Cancer; 2007 Jan; 46(1):27-36. PubMed ID: 17048234
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular cytogenetic findings in 43 aneurysmal bone cysts: aberrations of 17p mapped to 17p13.2 by fluorescence in situ hybridization.
Althof PA; Ohmori K; Zhou M; Bailey JM; Bridge RS; Nelson M; Neff JR; Bridge JA
Mod Pathol; 2004 May; 17(5):518-25. PubMed ID: 15044915
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloid leukemia and myelodysplastic syndromes following essential thrombocythemia treated with hydroxyurea: high proportion of cases with 17p deletion.
Sterkers Y; Preudhomme C; Laï JL; Demory JL; Caulier MT; Wattel E; Bordessoule D; Bauters F; Fenaux P
Blood; 1998 Jan; 91(2):616-22. PubMed ID: 9427717
[TBL] [Abstract][Full Text] [Related]
16. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases.
Kobayashi H; Montgomery KT; Bohlander SK; Adra CN; Lim BL; Kucherlapati RS; Donis-Keller H; Holt MS; Le Beau MM; Rowley JD
Blood; 1994 Nov; 84(10):3473-82. PubMed ID: 7949101
[TBL] [Abstract][Full Text] [Related]
18. A new nonrandom unbalanced t(17;20) in myeloid malignancies.
Patsouris C; Michael PM; Campbell LJ
Cancer Genet Cytogenet; 2002 Oct; 138(1):32-7. PubMed ID: 12419582
[TBL] [Abstract][Full Text] [Related]
19. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies.
Sato Y; Suto Y; Pietenpol J; Golub TR; Gilliland DG; Davis EM; Le Beau MM; Roberts JM; Vogelstein B; Rowley JD
Blood; 1995 Aug; 86(4):1525-33. PubMed ID: 7632960
[TBL] [Abstract][Full Text] [Related]
20. Rearrangement and expression of the p53 gene in myelodysplastic syndrome and acute myeloid leukemia.
Fenaux P; Collyn d'Hooghe M; Jonveaux P; Lai JL; Bauters F; Loucheux MH; Kerckaert JP
Nouv Rev Fr Hematol (1978); 1990; 32(5):341-4. PubMed ID: 2099408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]